|
Market Closed -
London S.E.
11:35:11 2026-09-09 am EDT
|
5-day change | 1st Jan Change | ||
| 1,803.50 GBX | +0.39% |
|
-3.63% | -1.15% |
| 09:53am | GSK plc Presents at Bernstein?s 23rd Annual Pan-European Strategic Decisions Conference, Sep-09-2026 08:00 AM | |
| 08:56am | The Fed's September Squeeze |  |
| Market Cap | 72.27B 97.89B 84.23B 79.31B 135B 9,315B 136B 940B 363B 4,745B 368B 360B 15,033B | P/E 2026 * |
13.7x | P/E 2027 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 92.1B 125B 107B 101B 172B 11,872B 173B 1,198B 463B 6,048B 468B 458B 19,160B | EV / Sales 2026 * |
2.71x | EV / Sales 2027 * | 2.52x |
| Free-Float |
92.75% | Yield 2026 * |
3.86% | Yield 2027 * | 4.16% |
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| GSK | Delayed | |
CBOE
| GSK | Real-time | |
|
Xetra
| GS71 | Delayed | |
|
Tradegate
| GS71 | Real-time | |
|
OTC Markets
| GLAXF | Delayed | |
|
Boerse Muenchen
| GS71 | Real-time | |
|
Börse Stuttgart
| GS71 | Delayed | |
|
Mexican S.E.
| GSK1 N | End-of-day quote | |
|
Deutsche Boerse AG
| GS71 | Delayed |
Last Transcript : GSK plc
| 1 day | +0.35% | ||
| 1 week | -3.63% | ||
| Current month | -2.70% | ||
| 1 month | -8.01% | ||
| 3 months | -5.72% | ||
| 6 months | -11.51% | ||
| Current year | -1.15% |
| 1 week | 1,772 |  | 1,911 |
| 1 month | 1,772 | | 1,972 |
| Current year | 1,690 | | 2,282 |
| 1 year | 1,455 | | 2,282 |
| 3 years | 1,242.5 | | 2,282 |
| 5 years | 1,242.5 | | 3,408.16 |
| 10 years | 1,242.5 | | 3,408.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | 52 | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
James Ford
CMP | Compliance Officer | - | 2018-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | 52 | 2026-05-05 |
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 67 | 2019-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/24/26 | Buy | Executive/Senior Manager | 9 | 0.0000% | ||
| 8/21/26 | Sell | Executive/Senior Manager | -28,978 | 0.0007% | ||
| 8/21/26 | Sell | Executive/Senior Manager | -49 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.39% | -3.63% | +23.15% | +24.88% | 97.52B | |
| +0.03% | -3.09% | +52.20% | +91.69% | 1,002B | |
| -0.76% | -1.52% | +49.94% | +66.34% | 649B | |
| +0.86% | -3.49% | +19.60% | +68.37% | 440B | |
| -0.80% | +0.06% | +28.73% | +35.45% | 346B | |
| -0.13% | -14.74% | +9.13% | +26.71% | 263B | |
| -1.90% | -2.61% | -2.67% | +7.41% | 250B | |
| -0.48% | -10.69% | +39.64% | +50.82% | 213B | |
| -1.06% | -1.70% | -16.73% | -57.36% | 201B | |
| -0.68% | -2.85% | +25.69% | +91.64% | 182B | |
| Average | -0.44% | -2.26% | +22.87% | +40.60% | 364.12B | |
| Weighted average by Cap. | -0.32% | -2.43% | +32.12% | +56.15% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.95B 45.98B 39.57B 37.26B 63.52B 4,376B 63.77B 442B 171B 2,229B 173B 169B 7,062B | 35.5B 48.08B 41.37B 38.96B 66.41B 4,575B 66.68B 462B 178B 2,331B 181B 177B 7,384B |
| Net income | 5.42B 7.34B 6.32B 5.95B 10.14B 699B 10.19B 70.53B 27.26B 356B 27.58B 26.98B 1,128B | 6.47B 8.76B 7.54B 7.1B 12.1B 834B 12.15B 84.13B 32.52B 425B 32.9B 32.18B 1,345B |
| Net Debt | 19.84B 26.87B 23.12B 21.77B 37.12B 2,557B 37.27B 258B 99.73B 1,303B 101B 98.71B 4,127B | 17.06B 23.11B 19.88B 18.72B 31.92B 2,199B 32.05B 222B 85.76B 1,120B 86.77B 84.89B 3,549B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-09 | GBX 1,803.50 | +0.39% | 3,218,789 |
| 26-09-08 | GBX 1,796.50 | -2.23% | 5,350,556 |
| 26-09-07 | GBX 1,837.50 | -0.49% | 4,623,292 |
| 26-09-04 | GBX 1,846.50 | -1.07% | 3,782,887 |
| 26-09-03 | GBX 1,866.50 | +0.27% | 4,089,944 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
